Nissay Asset Management Corp Neurocrine Biosciences Inc Transaction History
Nissay Asset Management Corp
- $15 Billion
- Q2 2024
A detailed history of Nissay Asset Management Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nissay Asset Management Corp holds 11,574 shares of NBIX stock, worth $1.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,574
Previous 11,173
3.59%
Holding current value
$1.3 Million
Previous $1.54 Million
3.44%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding NBIX
# of Institutions
640Shares Held
95.2MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.13 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$517 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$277 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$265 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...